Vegetable Capsules Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Vegetable Capsules Market is Segmented by Product Type (Hydroxypropyl Methylcellulose Capsules, Pullulan Capsules, and More), Source (Cellulose-Based, Pullulan-Based, and Starch-Based), Application (Pharmaceuticals, Herbal Products, and More), End User (Pharmaceutical Companies, Nutraceutical Companies, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market and Forecast are in Terms of Value (USD).

Vegetable Capsules Market Size and Share

Vegetable Capsules Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Vegetable Capsules Market Analysis by Mordor Intelligence

The vegetable capsules market size is expected to be valued at USD 1.93 billion in 2026. It is projected to grow from USD 2.09 billion in 2027 to USD 3.15 billion by 2032, registering a CAGR of 8.52% during the forecast period of 2027-2032. The vegetable capsules market is expanding as drug developers and supplement brands reduce reliance on gelatin-based supply chains. Vegetarian, vegan, halal, kosher, and clean-label requirements are making plant-derived shells more relevant to formulation and registration decisions. Moisture-sensitive products also support the shift because HPMC and pullulan can offer functional benefits for certain ingredients. Investment in local production is changing the competitive balance, especially where manufacturers seek shorter lead times and less exposure to import disruption. Cost premiums, volatile HPMC inputs, and lengthy supplier qualification cycles continue to limit adoption in price-sensitive applications.

Key Report Takeaways

  • By product type, HPMC capsules held 63.25% of the vegetable capsules market share in 2026, while pullulan capsules are projected to grow at an 8.82% CAGR through 2032.
  • By source, cellulose-based capsules accounted for 65.47% of the vegetable capsules market share in 2026, while pullulan-based capsules are forecast to expand at a 9.33% CAGR through 2032.
  • By application, nutraceuticals and dietary supplements accounted for 45.31% of the vegetable capsules market size in 2026, while herbal products are forecast to grow at a 9.57% CAGR through 2032.
  • By end user, nutraceutical companies held 43.78% of revenue in 2026, while CRO and CDMO companies are forecast to advance at a 9.84% CAGR through 2032.
  • By geography, North America held 36.94% of revenue in 2026, while Asia-Pacific is projected to grow at a 10.56% CAGR through 2032.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Vegetable Capsules Market Segment Analysis

By Product Type:

HPMC Leads as Pullulan Commands a Premium

HPMC capsules held 63.25% of revenue in 2026. Their position reflects compatibility with high-speed encapsulation equipment and established acceptance across the USP, Ph. Eur., and JP pharmacopeias. Gelling-aid-free versions also support formulations seeking a simpler ingredient statement. The material’s FDA GRAS status and existing Drug Master File infrastructure strengthen its fit with pharmaceutical customers. These factors make HPMC the principal volume platform in the vegetable capsules industry.

Pullulan capsules are forecast to expand at an 8.82% CAGR from 2027 to 2032, the highest rate among product types. Their oxygen-barrier properties make them relevant to premium nutraceutical products with shelf-life requirements. Starch-based capsules retain a narrower role where pricing or formulation chemistry favors a plant-starch shell. Other products include specialty formats such as enteric and dry-powder inhalation HPMC grades. Product development in the vegetable capsules market is moving toward applications that can support a premium over conventional shells.

Need more granular breakdown of segment shares?

Get tailored market insights for your requirements.

Vegetable Capsules Market Share by Product Type, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Vegetable Capsules Market Share by Product Type, 2026

By Source:

Cellulose-Based Anchors Volume as Pullulan-Based Grows Fastest

Cellulose-based materials accounted for 65.47% of the vegetable capsules market size in 2026. HPMC is derived from wood pulp through a cellulose ether synthesis route and has a long regulatory record. Major cellulose ether producers also support an established upstream supply chain for this segment. Existing formulation documentation and equipment compatibility reinforce the segment’s position. This supplier ecosystem makes cellulose-based products difficult to displace in regulated, high-volume uses. Its scale continues to anchor supply across pharmaceutical and supplement applications.

Pullulan-based products are forecast to grow at a 9.33% CAGR from 2027 to 2032. Lonza Capsugel’s October 2025 Organicaps launch showed a route for pullulan to serve brands that need both organic certification and a plant-based shell.[3] The material is attractive where oxygen protection and organic positioning justify a higher unit cost. Starch-based sources remain relevant in selected herbal and price-sensitive applications. Cellulose-based materials retain a structural advantage through documentation, supplier availability, and established production practice. The vegetable capsules market will therefore continue to combine high-volume cellulose demand with a smaller premium pullulan segment.

By Application:

Nutraceuticals Lead as Herbal Products Show Highest Momentum

Nutraceuticals and dietary supplements accounted for 45.31% of the vegetable capsules market size in 2026. The segment is driven by capsule material claims that are visible to consumers, including vegan, organic, halal, kosher, and allergen-free positioning. Supplement brands often select plant-based shells as part of the finished product’s label proposition. Product launches involving probiotics, enzymes, and botanical ingredients also create demand for low-moisture shell formats. This combination gives nutraceutical products a central role in the vegetable capsules market. It also makes certification and shelf-life performance relevant to purchasing decisions.

Herbal products are forecast to grow at a 9.57% CAGR from 2027 to 2032. Botanical extracts can present moisture and oxidation challenges that favor HPMC or pullulan over gelatin. This demand is based on formulation stability as well as ethical positioning. Pharmaceutical uses remain the second-largest application, although gelatin retains a wider role in the broader pharmaceutical capsule field. Export dossiers for halal and vegetarian markets support gradual conversion to plant-based shells in the Gulf Cooperation Council, Southeast Asia, and South Asia. Cosmetics, personal care, veterinary pharmaceuticals, and specialty food products add smaller sources of application diversity.

Segment this market the way your business does.

Get tailored market insights for your requirements.

Vegetable Capsules Market Share by Application, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Vegetable Capsules Market Share by Application, 2026

By End User:

Nutraceutical Firms Anchor Share as CRO and CDMOs Drive Growth

Nutraceutical companies held 43.78% of revenue in 2026. These customers adopted vegetable shells early because vegan and halal claims can directly influence retail product positioning. Preventive-wellness portfolios are also increasing the number of capsule-based stock-keeping units used by these companies. Established supplement brands need reliable access to certified shell types across multiple products. Nutraceutical firms are therefore the leading end-user group in the vegetable capsules market.

CRO and CDMO companies are projected to grow at a 9.84% CAGR from 2027 to 2032. Virtual pharmaceutical companies and biotechnology firms increasingly depend on contract partners for oral solid dosage development and manufacturing. CDMOs with pre-qualified HPMC suppliers and multi-pharmacopoeial Drug Master Files can support simultaneous filings in the United States, Europe, and Japan. This documentation can improve their appeal to clients that need multi-market regulatory submissions. Pharmaceutical companies remain the second-largest end-user group. Their use of dossier-registered vegetable shells is smaller in volume but can generate higher value per capsule than nutraceutical-grade supply.

Geography Analysis

North America: Infrastructure and Compliance Intensity Drive Scale

North America held 36.94% of revenue in 2026. The region combines high supplement consumption with pharmaceutical manufacturing requirements that support demand for USP and NF-compliant plant-based shells. FDA good manufacturing practice requirements under 21 CFR Part 111 and traceability requirements under DSHEA support purchasing from suppliers with validated quality systems. ACG announced a phased USD 200 million investment in Atlanta in October 2025 for its first U.S. hard-shell capsule manufacturing operations, with early 2027 operations planned. SD Head USA also announced a USD 65 million North Carolina plant in November 2025 with capacity exceeding 20 billion HPMC capsules each year. These investments show that local capacity, regulatory responsiveness, and tariff resilience are becoming more important in the vegetable capsules market.

Asia-Pacific: Manufacturing Expansion Supports Demand

Asia-Pacific is projected to grow at a 10.56% CAGR from 2027 to 2032. India’s export-oriented pharmaceutical sector creates demand for capsules supported by established quality documentation. The revised Schedule M framework has been fully applicable since January 2026, raising compliance expectations for drug manufacturers. The region’s growing supplement activity gives the vegetable capsules market a separate demand base alongside contract manufacturing. China, South Korea, and Japan add substantial manufacturing capability and higher-value product demand. Sustainability preferences and consumer-health spending support interest in pullulan and specialty HPMC products across selected markets.

Europe, South America, and the Middle East and Africa: Regulatory and Certification Needs Shape Adoption

Europe’s TiO₂ food and supplement restrictions continue to influence reformulation of capsule shells. The supplied material states that TiO₂ remains permitted in medicines, while the food supplement ban remains in force. This distinction encourages suppliers to develop TiO₂-free alternatives for the supplement channel. Brazil and Argentina offer earlier-stage demand through nutraceutical manufacturing, although the cost gap with gelatin remains a constraint. Gulf Cooperation Council markets place importance on authenticated halal and kosher documentation for imports. South Africa and other Middle East and Africa pharmaceutical markets add incremental demand where certification and supply-chain compliance affect supplier choice.

Vegetable Capsules Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market Concentration

Vegetable Capsules Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The vegetable capsules market is moderately concentrated, with globally integrated manufacturers holding significant pharmaceutical-grade volume and regional producers competing on price, capacity, and certification. Lonza agreed in March 2026 to divest its Capsules and Health Ingredients business to Lone Star Funds for an enterprise value of CHF 2.3 billion, equal to USD 3 billion in the supplied draft, while retaining a 40% stake. The transaction places the Vcaps, Plantcaps, and Organicaps product lines under a standalone ownership structure. Lonza’s change in ownership may increase commercial focus on the capsule platform. It also underscores the value assigned to established capsule portfolios with global regulatory credentials.

ACG is pursuing capacity expansion and product differentiation in the vegetable capsules market. Its Atlanta investment targets both gelatin and HPMC hard-shell capsules and is designed to create a U.S. production base. Lonza Capsugel’s Organicaps launch is another example of differentiation through organic-certified pullulan capsules. These strategies place greater emphasis on locally available capacity, specialized shell properties, and evidence supporting certification claims.

Chinese producers, including Shandong Head Group, Zhejiang Honghui, and Shanxi Guangsheng, compete through vertically integrated supply from HPMC powder to capsule shells. This structure can improve control over cost and raw-material availability. Certification investment also supports their effort to supply premium Western customers. Pharmaceutical customers continue to require Drug Master Files across USP, Ph. Eur., and JP, along with quality certifications such as ISO 9001 and ISO 14001. These documentation requirements remain a barrier for smaller producers seeking regulated pharmaceutical accounts. 

Vegetable Capsules Industry Leaders

  1. ACG Associated Capsules Private Limited

  2. Farmacápsulas SA

  3. Lonza Group AG

  4. Nectar Lifesciences Ltd

  5. Qingdao Yiqing Biotechnology Co. Ltd

  6. *Disclaimer: Major Players sorted in no particular order

Vegetable Capsules Market Companies Covered in this Report

  • ACG Associated Capsules Private Limited
  • Bright Pharma Caps
  • CapsCanada Corporation
  • Farmacápsulas SA
  • HealthCaps India Ltd
  • Lefancaps
  • Lonza Group
  • Natural Capsules Limited
  • Nectar Lifesciences
  • Procaps Group
  • Qingdao Yiqing Biotechnology Co. Ltd
  • Qualicaps Co. Ltd
  • Roxlor International
  • Shandong Head Group Co. Ltd
  • Shanxi Guangsheng Medicinal Capsule Co. Ltd
  • SIRIO Pharma Co. Ltd
  • Suheung Co. Ltd
  • Sunil Healthcare Limited
  • Zhejiang Honghui Capsule Co. Ltd
  • Zhejiang Huili Capsules Co. Ltd

Recent Industry Developments in Vegetable Capsules Market

  • March 2026: Lonza signed a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3 billion (USD 3 billion), with Lonza retaining a 40% stake and receiving CHF 1.7 billion (USD 2.2 billion) in upfront cash. The transaction, expected to close in H2 2026 subject to regulatory approvals, repositions the Vcaps, Plantcaps, and Organicaps vegetable capsule lines under independent private equity ownership and is the final step in Lonza's transformation into a pure-play CDMO.
  • January 2026: Yuexi Capsules (Zhejiang) commissioned a new HPMC capsule production line of plant origin as part of its long-term capacity expansion strategy, fully GMP- and ISO certified, targeting Europe and international supplement markets.
  • November 2025: Shandong Head Group (SD Head USA) announced a USD 65 million investment to establish a manufacturing facility in Gaston County, North Carolina, producing Healsee brand vegetarian HPMC hard-shell capsules with capacity exceeding 20 billion capsules annually. The facility targets late 2026 operations and is designed to reduce tariff exposure and lead times for North American nutraceutical customers.

Table of Contents for Vegetable Capsules Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Vegetarian, Vegan and Clean-Label Dosage Forms
    • 4.2.2 Expansion of Nutraceuticals, Functional Nutrition and Preventive Healthcare
    • 4.2.3 Growing Use of Plant-Based Capsules for Moisture-Sensitive Formulations
    • 4.2.4 Increasing Pharmaceutical and Nutraceutical Manufacturing in Asia-Pacific
    • 4.2.5 TiO2-Free and Natural-Color Reformulation of Capsule Shells
    • 4.2.6 Localized HPMC Capacity Reducing Lead Times and Import Exposure
  • 4.3 Market Restraints
    • 4.3.1 Higher Production Cost Compared with Gelatin Capsules
    • 4.3.2 Volatility in HPMC, Cellulose Pulp and Energy Input Costs
    • 4.3.3 Regional Variability in Moisture-Controlled Storage and Transport
    • 4.3.4 Lengthy GMP Qualification and Multi-Pharmacopoeial Compliance
  • 4.4 Value and Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Hydroxypropyl Methylcellulose (HPMC) Capsules
    • 5.1.2 Pullulan Capsules
    • 5.1.3 Starch-Based Capsules
    • 5.1.4 Others
  • 5.2 By Source
    • 5.2.1 Cellulose-Based
    • 5.2.2 Pullulan-Based
    • 5.2.3 Starch-Based
  • 5.3 By Application
    • 5.3.1 Pharmaceuticals
    • 5.3.2 Nutraceuticals & Dietary Supplements
    • 5.3.3 Cosmetics & Personal Care
    • 5.3.4 Herbal Products
    • 5.3.5 Others
  • 5.4 By End User
    • 5.4.1 Pharmaceutical Companies
    • 5.4.2 Nutraceutical Companies
    • 5.4.3 CRO/CDMO Companies
    • 5.4.4 Others
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.3.1 ACG Associated Capsules Private Limited
    • 6.3.2 Bright Pharma Caps Inc.
    • 6.3.3 CapsCanada Corporation
    • 6.3.4 Farmacápsulas SA
    • 6.3.5 HealthCaps India Ltd
    • 6.3.6 Lefancaps
    • 6.3.7 Lonza Group AG
    • 6.3.8 Natural Capsules Limited
    • 6.3.9 Nectar Lifesciences Ltd
    • 6.3.10 Procaps Group
    • 6.3.11 Qingdao Yiqing Biotechnology Co. Ltd
    • 6.3.12 Qualicaps Co. Ltd
    • 6.3.13 Roxlor International
    • 6.3.14 Shandong Head Group Co. Ltd
    • 6.3.15 Shanxi Guangsheng Medicinal Capsule Co. Ltd
    • 6.3.16 SIRIO Pharma Co. Ltd
    • 6.3.17 Suheung Co. Ltd
    • 6.3.18 Sunil Healthcare Limited
    • 6.3.19 Zhejiang Honghui Capsule Co. Ltd
    • 6.3.20 Zhejiang Huili Capsules Co. Ltd

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment

Global Vegetable Capsules Market Report Scope

As per the scope of the report, vegetable capsules are plant-based capsule shells used to encapsulate pharmaceutical drugs, dietary supplements, nutraceuticals, and herbal products. They are typically manufactured from hydroxypropyl methylcellulose (HPMC), pullulan, or other plant-derived materials, providing a vegetarian and vegan alternative to traditional gelatin capsules derived from animal sources.

The vegetable capsules market is segmented by product type, source, application, end user, and geography. By product type, the market is segmented into hydroxypropyl methylcellulose (HPMC) capsules, pullulan capsules, starch-based capsules, and others. By source, the market is segmented into cellulose-based, pullulan-based, and starch-based. By application, the market is segmented into pharmaceuticals, nutraceuticals & dietary supplements, cosmetics & personal care, herbal products, and others. By end user, the market is segmented into pharmaceutical companies, nutraceutical companies, CRO/CDMO companies, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers estimated market sizes and market trends for 17 countries across major regions worldwide. The report offers market value (in USD) for the above segments.

Segmentation Overview

By Product Type
Vegetable Capsules Market segmentation breakdown
Hydroxypropyl Methylcellulose (HPMC) Capsules
Pullulan Capsules
Starch-Based Capsules
Others
By Source
Vegetable Capsules Market segmentation breakdown
Cellulose-Based
Pullulan-Based
Starch-Based
By Application
Vegetable Capsules Market segmentation breakdown
Pharmaceuticals
Nutraceuticals & Dietary Supplements
Cosmetics & Personal Care
Herbal Products
Others
By End User
Vegetable Capsules Market segmentation breakdown
Pharmaceutical Companies
Nutraceutical Companies
CRO/CDMO Companies
Others
By Geography
Vegetable Capsules Market segmentation breakdown
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Vegetable Capsules Market segmentation breakdown
By Product Type Hydroxypropyl Methylcellulose (HPMC) Capsules
Pullulan Capsules
Starch-Based Capsules
Others
By Source Cellulose-Based
Pullulan-Based
Starch-Based
By Application Pharmaceuticals
Nutraceuticals & Dietary Supplements
Cosmetics & Personal Care
Herbal Products
Others
By End User Pharmaceutical Companies
Nutraceutical Companies
CRO/CDMO Companies
Others
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America

Key Questions Answered in the Report

What is the forecast growth rate for vegetable capsules?

The vegetable capsules market is projected to grow at an 8.52% CAGR from 2027 to 2032 and reach USD 3.15 billion by 2032. Demand is supported by dietary certification needs, formulation performance, and supplement product development.

Which capsule material holds the leading share?

HPMC capsules lead with a 63.25% share in 2026. Equipment compatibility, established pharmacopoeial acceptance, Drug Master File infrastructure, and material familiarity support their use in high-volume pharmaceutical and nutraceutical applications.

Why are pullulan capsules growing faster than other capsule types?

Pullulan capsules are projected to grow at an 8.82% CAGR through 2032 because their oxygen-barrier properties support premium, oxidation-sensitive formulations. Organic certification can also give supplement brands another route to differentiate finished products.

Which application has the largest demand for vegetable capsules?

Nutraceuticals and dietary supplements hold the largest application share at 45.31% in 2026. Consumer-facing claims such as vegan, halal, kosher, organic, and allergen-free status influence shell material choice in this application.

Which region is expanding the fastest?

Asia-Pacific is forecast to grow at a 10.56% CAGR through 2032. The region combines pharmaceutical production, export-oriented quality requirements, contract manufacturing, and rising use of preventive-health supplements.

What are the key constraints on adoption of plant-based capsule shells?

Higher costs than gelatin, HPMC input volatility, lengthy supplier qualification, and storage conditions can slow adoption. These constraints are most relevant where customers prioritize cost or rely on long supply chains without robust handling controls.

Page last updated on: